Biotech Profile
One Biosciences – First clinical-grade single-cell transcriptomic platform for FFPE samples targets tumor heterogeneity gap
Paris biotech One Biosciences outlines how single-cell transcriptomics can transform precision oncology by capturing the cellular complexity that traditional bulk sequencing misses. Founded by Institut Curie pioneer Dr. Céline Vallot, the company has secured over €20 million to bring OneMap™
4 August 2025